WuXi AppTec Past Earnings Performance
Past criteria checks 4/6
WuXi AppTec has been growing earnings at an average annual rate of 36.8%, while the Life Sciences industry saw earnings growing at 19.1% annually. Revenues have been growing at an average rate of 31% per year. WuXi AppTec's return on equity is 17.5%, and it has net margins of 23.8%.
Key information
36.8%
Earnings growth rate
34.5%
EPS growth rate
Life Sciences Industry Growth | 26.8% |
Revenue growth rate | 31.0% |
Return on equity | 17.5% |
Net Margin | 23.8% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How WuXi AppTec makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 40,341 | 9,607 | 3,821 | 1,441 |
30 Sep 23 | 40,502 | 9,512 | 3,617 | 1,550 |
30 Jun 23 | 40,470 | 9,491 | 3,718 | 1,624 |
31 Mar 23 | 39,844 | 9,339 | 3,695 | 1,691 |
31 Dec 22 | 39,355 | 8,814 | 3,674 | 1,614 |
30 Sep 22 | 34,776 | 8,913 | 3,595 | 1,387 |
30 Jun 22 | 30,122 | 7,058 | 3,269 | 1,195 |
31 Mar 22 | 26,426 | 5,240 | 3,097 | 1,018 |
31 Dec 21 | 22,902 | 5,097 | 2,934 | 942 |
30 Sep 21 | 21,242 | 4,154 | 2,739 | 862 |
30 Jun 21 | 19,841 | 3,918 | 2,691 | 764 |
31 Mar 21 | 18,298 | 4,157 | 2,610 | 772 |
31 Dec 20 | 16,535 | 2,960 | 2,440 | 693 |
30 Sep 20 | 15,408 | 2,454 | 2,339 | 651 |
30 Jun 20 | 14,209 | 2,512 | 2,195 | 680 |
31 Mar 20 | 13,290 | 1,768 | 2,042 | 605 |
31 Dec 19 | 12,872 | 1,851 | 1,964 | 590 |
30 Sep 19 | 11,971 | 2,097 | 1,836 | 554 |
30 Jun 19 | 11,099 | 2,045 | 1,771 | 503 |
31 Mar 19 | 10,241 | 2,356 | 1,614 | 479 |
31 Dec 18 | 9,614 | 2,261 | 1,485 | 437 |
30 Sep 18 | 9,009 | 2,092 | 1,379 | 376 |
30 Jun 18 | 8,509 | 1,757 | 1,178 | 483 |
31 Mar 18 | 8,139 | 1,181 | 1,210 | 375 |
31 Dec 17 | 7,765 | 1,227 | 1,269 | 306 |
31 Dec 16 | 6,116 | 975 | 1,240 | 0 |
31 Dec 15 | 4,883 | 349 | 1,179 | 0 |
31 Dec 14 | 4,140 | 462 | 835 | 0 |
Quality Earnings: WX8 has high quality earnings.
Growing Profit Margin: WX8's current net profit margins (23.8%) are higher than last year (22.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: WX8's earnings have grown significantly by 36.8% per year over the past 5 years.
Accelerating Growth: WX8's earnings growth over the past year (9%) is below its 5-year average (36.8% per year).
Earnings vs Industry: WX8 earnings growth over the past year (9%) exceeded the Life Sciences industry 6.5%.
Return on Equity
High ROE: WX8's Return on Equity (17.5%) is considered low.